Announcement of cancellation of treasury stock
Filed with TSE · · 1 page · English
Summary by 6ix AI
Asahi Kasei Corporation has announced the cancellation of treasury stock as resolved by its Board of Directors. The cancellation will involve common stock and is scheduled for a specific date. This action will reduce the number of issued shares and treasury stock held by the company.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Asahi Kasei Corporation on 6ix
Earlier from Asahi Kasei
- Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults
- Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics
- Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing
- Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
- Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy
Later from Asahi Kasei
All Asahi Kasei news releasesFollow Asahi Kasei into a list and get an email when it puts out news.
Follow Asahi Kasei